Trial Profile
A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety Profile and Pharmacokinetic Parameters of Udenafil 150 mg in Healthy Mexican Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Udenafil (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction; Portal hypertension; Pulmonary hypertension
- Focus Adverse reactions
- Sponsors Takeda
- 29 Oct 2013 New trial record